Biocept undertakes 1-for-30 reverse stock split
monsitj
- Biocept (NASDAQ:BIOC) said it has undertaken a 1-for-30 reverse stock split and the common shares will begin trading on a split-adjusted basis on Tuesday market open.
- The SA Quant Rating on BIOC is Strong Sell, while the average Wall Street Analysts' Rating is Hold. YTD, the stock has fallen ~61%, see chart here.